Terms: = Uterine cancer AND MSN, P26038, 4478, ENSG00000147065
29 results:
1. Ultrasound-Triggered Azo Free Radicals for Cervical cancer Immunotherapy.
Wang Y; Lv B; Wang H; Ren T; Jiang Q; Qu X; Ni D; Qiu J; Hua K
ACS Nano; 2024 Apr; 18(17):11042-11057. PubMed ID: 38627898
[TBL] [Abstract] [Full Text] [Related]
2. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
Chen Q; Shi H; Lu W; Lu B
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
[TBL] [Abstract] [Full Text] [Related]
3. Left Lateral Endosurgical Extraperitoneal Total Hysterectomy with Para-Aortic and Pelvic Lymphadenectomy: A Novel Approach for the Obese Patient with Endometrial cancer.
Ferron G; De Santiago J; Querleu D; Martinez A; Angeles MA; Boulet B; Guyon F; Zapardiel I
J Minim Invasive Gynecol; 2018; 25(4):730-736. PubMed ID: 29229578
[TBL] [Abstract] [Full Text] [Related]
4. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
[TBL] [Abstract] [Full Text] [Related]
5. Semiquantitative perfusion combined with diffusion-weighted MR imaging in pre-operative evaluation of endometrial carcinoma: results in a group of 57 patients.
Ippolito D; Cadonici A; Bonaffini PA; Minutolo O; Casiraghi A; Perego P; Sironi S
Magn Reson Imaging; 2014 Jun; 32(5):464-72. PubMed ID: 24629513
[TBL] [Abstract] [Full Text] [Related]
6. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract] [Full Text] [Related]
7. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract] [Full Text] [Related]
8. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.
Huang IP; Sun SP; Cheng SH; Lee CH; Wu CY; Yang CS; Lo LW; Lai YK
Mol Cancer Ther; 2011 May; 10(5):761-9. PubMed ID: 21411714
[TBL] [Abstract] [Full Text] [Related]
9. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
Lyng H; Brøvig RS; Svendsrud DH; Holm R; Kaalhus O; Knutstad K; Oksefjell H; Sundfør K; Kristensen GB; Stokke T
BMC Genomics; 2006 Oct; 7():268. PubMed ID: 17054779
[TBL] [Abstract] [Full Text] [Related]
10. Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers.
Takehara K; Kubushiro K; Kiguchi K; Ishiwata I; Tsukazaki K; Nozawa S; Iwamori M
Jpn J Cancer Res; 2002 Oct; 93(10):1129-37. PubMed ID: 12417043
[TBL] [Abstract] [Full Text] [Related]
11. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract] [Full Text] [Related]
12. Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody msn-1 to endometrial adenocarcinoma in vitro and in vivo.
Kaneta Y; Tsukazaki K; Kubushiro K; Sakayori M; Ueda M; Nozawa S
Oncol Rep; 2000; 7(5):1099-106. PubMed ID: 10948346
[TBL] [Abstract] [Full Text] [Related]
13. Detection of endometrial cancer by flow cytometry using two monoclonal antibodies.
Kobiki K; Tsukasaki K; Kubushiro K; Kobayashi Y; Hasegawa K; Fukuchi T; Banno K; Nozawa S
Cytometry; 1999 Jun; 36(2):150-6. PubMed ID: 10554163
[TBL] [Abstract] [Full Text] [Related]
14. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (msn-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract] [Full Text] [Related]
15. [Applications of tumor markers to the screening of endometrial and ovarian cancers].
Nozawa S; Takamatsu K; Tsukazaki K; Udagawa Y
Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627
[TBL] [Abstract] [Full Text] [Related]
16. Establishment of a quantitative assay of abnormal glycolipid expression in endometrial cells, and its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Kubushiro K; Sakayori M; Nozawa S
Clin Cancer Res; 1996 Apr; 2(4):749-54. PubMed ID: 9816226
[TBL] [Abstract] [Full Text] [Related]
17. [Abnormal expression of carbohydrate chain and its mechanism in endometrial cancer].
Kubushiro K; Tsukazaki K; Sakuma Y; Nozawa S
Nihon Rinsho; 1995 Jul; 53(7):1753-9. PubMed ID: 7630016
[TBL] [Abstract] [Full Text] [Related]
18. [Characterization of anti human uterine endometrial cancer antibody (msn-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract] [Full Text] [Related]
19. [Abnormal expression of glycoconjugate associated with the development of endometrial cancer: a basic study and its usefulness in clinical application].
Tsukazaki K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):789-801. PubMed ID: 8371008
[TBL] [Abstract] [Full Text] [Related]
20. Subcellular localization of blood group Leb carbohydrate antigen (msn-1-reactive antigen) in endometrial cancer cells.
Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
[TBL] [Abstract] [Full Text] [Related]
[Next]
